Demand for Endometriosis Treatment to Account for over US$ 4 Bn by 2030; Oral Contraceptives Remain the Leading Category, Says a New FMI Report

In order to
sustain intense competition in the global endometriosis treatment market,
prominent players must develop new drugs with multiple indicators to treat
endometriosis for boosting their product sales.

Future Market
Insights (FMI), Dubai:
Tech-driven
advancements such as molecular diagnostics and non-invasive treatment are
driving the endometriosis treatment market. Rising prevalence of gynecological disorders is further
bolstering the growth of endometriosis treatment market. FMI projects the
global revenue pool of endometriosis treatment market to surpass US$ 4 Bn by
2030.

“Therapeutically-advanced
treatment alternatives for endometriosis have gained widespread acceptance in
recent years. Leading innovators continue to accelerate the launch of clinical
and scientific therapeutic agents which will push the market growth during the
course of forecast period (2019 – 2030),” says FMI in a new study.

Request report sample with 200+ pages to gain in-depth insightshttps://www.futuremarketinsights.com/reports/sample/rep-gb-3870

Key Takeaways of
Endometriosis Treatment Market Study

  • Oral contraceptives
    continue to lead in the global endometriosis treatment market.
  • Progestins will
    witness gradual rise during the course of projection period.
  • Healthcare
    professionals continue to favor hormonal therapy to treat endometriosis.
  • Pain management is
    projected to gain significant momentum to treat endometriosis over the forecast
    period.
  • Hospital
    pharmacies continue to capture leading value proportion in endometriosis
    market.  
  • North America and
    Europe will collectively capture leading revenue share in endometriosis treatment
    market through 2029.

Endometriosis
Treatment Market – Key Growth Factors

  • Rapid investments
    by key stakeholders in the global endometriosis market are accelerating market
    growth.
  • Rising awareness
    regarding gynecological disorders among women is bolstering market growth.
  • Rapid
    technological advancements continue to propel the growth of endometriosis
    treatment market.
  • Growing government
    expenditure in endometriosis treatment market is supporting market growth in
    Asia Pacific.

Endometriosis Treatment
Market – Key Restraint

  • Post-therapy
    problems such as leg cramps, indigestion, and bloating are restraining market
    growth.

Explore the full endometriosis treatment market report with 155 illustrative figures, 41 data tables and table of contents. Request ToC of the study athttps://www.futuremarketinsights.com/askus/rep-gb-3870

Competitive
Landscape

Prominent players profiled in this FMI study include,
but are not limited to, Sun Pharmaceutical Industries Limited, Mylan N.V., Teva
Pharmaceutical Industries Ltd., Myovant Sciences Ltd., Amneal Pharmaceuticals,
Inc., Debiopharm Group, AbbVie Inc., Endoceutics, Inc., and Noven
Pharmaceuticals, Inc. Hormonal therapy continues to be preferred by key players
in the global endometriosis treatment market. Minimal risks and enhanced
effectiveness associated with hormonal therapy are escalating its practice
amongst healthcare professionals and other key stakeholders.

More about the
Report

This Future Market Insights study of 254 pages
provides all-inclusive insights on the global endometriosis treatment market. The
market analysis is based on drug (oral contraceptives, progestins, NSAIDs, GnRH
analogues, LNR-IUDs), treatment type (hormonal therapy, pain management),
distribution channel (hospital pharmacies, retail pharmacies, drugstores,
ecommerce) across seven regions (North America, Latin America, Europe, South
Asia, East Asia, Oceania, Middle East & Africa).

Explore Extensive
Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Landscape

  • Gene Synthesis MarketGet FMI’s latest study on the global gene synthesis market covering important market dynamics, global industry analysis, and current growth parameters for predefined projection period (2019-2029).
  • Protein A Resins MarketObtain comprehensive analysis on the global protein A resins market through FMI’s incisive insights covering growth prospects, opportunities and challenges for 2016-2026.
  • Generic Injectable MarketFMI’s deep-dive report on the global generic injectable market encompasses key end-use industries, market leaders along with product portfolio and market share for 2019-2029.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact Us

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

FMI Blog

Leave a Reply

Your email address will not be published. Required fields are marked *